BlueCrest Capital Management’s NuVasive, Inc. NUVA Stock Holding History

BlueCrest Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-23,842	Closed	-$1.33M	–	346
2020 Q2	$1.33M	Sell	23,842 -27,158	-53%	-$1.57M	0.07%	152
2020 Q1	$2.58M	Buy	+51,000	New	+$3.42M	0.18%	73
2018 Q2	–	Sell	-5,008	Closed	-$261K	–	1917
2018 Q1	$261K	Buy	+5,008	New	+$254K	0.01%	1146
2017 Q4	–	Sell	-11,676	Closed	-$648K	–	1161
2017 Q3	$648K	Buy	+11,676	New	+$773K	0.03%	452
2017 Q2	–	Sell	-2,696	Closed	-$201K	–	1155
2017 Q1	$201K	Buy	+2,696	New	+$196K	0.01%	636
2016 Q1	–	Sell	-6,857	Closed	-$371K	–	1181
2015 Q4	$371K	Buy	+6,857	New	+$350K	0.02%	670

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BlueCrest Capital Management's NUVA Position: Q3 2020 in Review

BlueCrest Capital Management sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 23,842 shares — an estimated $1.33M sold.

BlueCrest Capital Management first reported a position in NUVA in Q4 2015 and held it in 6 quarters. The position peaked at $2.58M in Q1 2020. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

BlueCrest Capital Management reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
BlueCrest Capital Management sold 23,842 NuVasive, Inc. shares in Q3 2020, an estimated $1.33M.
BlueCrest Capital Management first reported a position in NuVasive, Inc. in Q4 2015 and held it in 6 quarters.
BlueCrest Capital Management's NuVasive, Inc. position peaked at $2.58M in Q1 2020.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on BlueCrest Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.